zenocutuzumab
merus
['meru', 'zenocutuzumab', 'merus']
merus presents clinical data on zenocutuzumab (zeno) in nrg1-fusion (nrg1+) cancer at the 2022 american society of clinical oncology (asco) annual meeting (oral abstract) 
World News Guru is completely free and offers a broad range of media content from a varied and extensive range of sources.